Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver

[1]  H. Matsumoto,et al.  Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer , 2012, Investigational New Drugs.

[2]  V. Seshan,et al.  A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis , 2012, Cell.

[3]  R. Kerbel,et al.  Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models , 2012, Gut.

[4]  M. Zollo,et al.  Tumor microenvironment: a main actor in the metastasis process , 2012, Clinical & Experimental Metastasis.

[5]  Brian Bierie,et al.  Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. , 2011, The Journal of clinical investigation.

[6]  G. Merlino,et al.  The Two Faces of Interferon-γ in Cancer , 2011, Clinical Cancer Research.

[7]  Robert A. Weinberg,et al.  Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. , 2011, Seminars in cancer biology.

[8]  M. Karin,et al.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.

[9]  Anne E Carpenter,et al.  Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. , 2011, The Journal of clinical investigation.

[10]  Roy M. Williams,et al.  S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression , 2011, Molecular Cancer Research.

[11]  Paula D. Bos,et al.  Modeling metastasis in the mouse. , 2010, Current opinion in pharmacology.

[12]  Chronic Disease Division.  Cancer facts and figures , 2010 .

[13]  Harald J. Maier,et al.  BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression. , 2010, Genes & cancer.

[14]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[15]  F. Balkwill.  Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.

[16]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[17]  Sonja Loges,et al.  Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. , 2009, Cancer cell.

[18]  M. Taketo,et al.  Mouse models of colon cancer. , 2009, Gastroenterology.

[19]  M. Karin,et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.

[20]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[21]  Hiroyuki Aburatani,et al.  The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.

[22]  R. Weinberg,et al.  Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.

[23]  M. Karin,et al.  The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. , 2008, Trends in molecular medicine.

[24]  G. Mundy.  The premetastatic niche , 2008 .

[25]  N. Mukaida,et al.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. , 2008, The Journal of clinical investigation.

[26]  N. Colburn,et al.  AP-1 a target for cancer prevention. , 2007, Current cancer drug targets.

[27]  M. Weiser,et al.  Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. , 2007, Cancer letters.

[28]  Ramon Mangues,et al.  Tumorigenesis and Neoplastic Progression Orthotopic Microinjection of Human Colon Cancer Cells in Nude Mice Induces Tumor Foci in All Clinically Relevant Metastatic Sites , 2007 .

[29]  R. Kaplan,et al.  Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond , 2007, Cancer and Metastasis Reviews.

[30]  Yehia Mechref,et al.  A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker , 2006, Proceedings of the National Academy of Sciences.

[31]  S. Rafii,et al.  Preparing the "soil": the premetastatic niche. , 2006, Cancer research.

[32]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[33]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[34]  J. Erler,et al.  Lysyl oxidase mediates hypoxic control of metastasis. , 2006, Cancer research.

[35]  F. Marincola,et al.  Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture , 2006, Cancer Immunology, Immunotherapy.

[36]  M. Bueter,et al.  Feasibility and limits of an orthotopic human colon cancer model in nude mice. , 2006, Comparative medicine.

[37]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[38]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[39]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[40]  Wolfgang Schima,et al.  Liver metastases of colorectal cancer: US, CT or MR? , 2005, Cancer imaging : the official publication of the International Cancer Imaging Society.

[41]  R. Weissleder,et al.  A novel mouse model for segmental orthotopic colon cancer , 2005, International journal of cancer.

[42]  I. B. Borel Rinkes,et al.  Mouse Models of Colorectal Cancer and Liver Metastases , 2005, Digestive Surgery.

[43]  D. Noonan,et al.  CXCL1/Macrophage Inflammatory Protein-2-Induced Angiogenesis In Vivo Is Mediated by Neutrophil-Derived Vascular Endothelial Growth Factor-A1 , 2004, The Journal of Immunology.

[44]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[45]  L. Coussens,et al.  MMP9 potentiates pulmonary metastasis formation. , 2002, Cancer cell.

[46]  D. Lindner,et al.  The IFN-induced GTPase, mGBP-2: Role in IFN-γ induced murine fibroblast proliferation , 2001 .

[47]  F. Schmitz,et al.  Functional Expression of HGF and Its Receptor in Human Colorectal Cancer , 2000, Digestion.

[48]  R. Gamagami,et al.  An orthotopic mouse model of remetastasis of human colon cancer liver metastasis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  R. Gamagami,et al.  A nude mouse model of massive liver and lymph node metastasis of human colon cancer. , 2000, Anticancer research.

[50]  I. Thorup,et al.  Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. , 2000, Comparative medicine.

[51]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[52]  Robert M. Hoffman,et al.  An ultra-metastatic model of human colon cancer in nude mice , 1999, Clinical & Experimental Metastasis.

[53]  A. Raz,et al.  Autocrine motility factor and the extracellular matrix. II. Degradation or remodeling of substratum components directs the motile response of tumor cells , 1998, International journal of cancer.

[54]  P. Musiani,et al.  Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene , 1993 .

[55]  C. Tzeng,et al.  An animal model for colon cancer metastatic cell line with enhanced metastasizing ability , 1991, Diseases of the colon and rectum.

[56]  Smith Br.  Regulation of hematopoiesis. , 1990 .

[57]  A W Partin,et al.  Fourier analysis of cell motility: correlation of motility with metastatic potential. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[58]  I. Fidler,et al.  Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. , 1988, Cancer research.

[59]  I. Fidler,et al.  In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. , 1988, Cancer research.

[60]  Y. Kim,et al.  An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability. , 1987, Cancer research.

[61]  M. Fraga,et al.  Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors. , 2013, Cancer Research.

[62]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[63]  S. Nedospasov,et al.  Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. , 2006, International review of cytology.

[64]  D. Lindner,et al.  The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-gamma-induced murine fibroblast proliferation. , 2002, The Journal of biological chemistry.

[65]  P. Musiani,et al.  Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. , 1993, International journal of cancer.

[66]  Clark,et al.  Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. , 1986, Blood.